Table 3.
CD antigen | Study group % | Control group % | P-value |
---|---|---|---|
CD3+ | 62·93 ± 10·63 | 73·77 ± 6·22 | 0·03 |
CD2+ | 70·37 ± 6·95 | 80·26 ± 6·07 | < 0·01 |
CD7+ | 46·17 ± 15·80 | 67·93 ± 12·95 | < 0·01 |
CD3+ CD4– CD8− | 6·00 ± 2·08 | 4·80 ± 1·77 | 0·24 |
CD2+ CD3− CD7+ | 8·71 ± 5·80 | 5·87 ± 2·94 | 0·24 |
CD4+ | 35·23 ± 9·31 | 45·00 ± 5·81 | 0·03 |
CD62L+ | 71·98 ± 5·14 | 79·88 ± 1·59 | 0·003 |
CD4+ CD62L+ | 28·49 ± 8·93 | 40·80 ± 4·93 | 0·01 |
CD4+ CD69+ | 0·15 ± 0·07 | 0·15 ± 0·11 | 0·85 |
CD4+ CD69− | 35·58 ± 8·98 | 45·11 ± 5·61 | 0·03 |
CD4+ CD25+ | 9·12 ± 2·50 | 9·67 ± 2·54 | 0·67 |
CD4+ CD25+ CD62L+ | 7·22 ± 2·12 | 8·31 ± 2·76 | 0·39 |
CD4+ CD25+ CD69− | 9·62 ± 2·78 | 9·29 ± 2·08 | 0·79 |
CD4+ CD152+ | 2·11 ± 2·26 | 6·91 ± 11·74 | 0·29 |
CD25− CD122+ | 33·33 ± 8·64 | 27·43 ± 4·06 | 0·11 |
CD8α+ CD8β+ | 20·39 ± 5·12 | 23·45 ± 4·34 | 0·22 |
CD8α+ CD8β− | 3·87 ± 1·95 | 1·90 ± 1·05 | 0·03 |
CD8+ CD28− | 29 ± 5·01 | 25·97 ± 3·51 | 0·12 |
TCRγδ+ | 12·26 ± 2·46 | 15·63 ± 6·68 | 0·21 |
TCRγδ+ CD84 | 10·02 ± 2·12 | 10·34 ± 5·23 | 0·88 |
TCRγδ+ CD8+ | 1·20 ± 0·98 | 4·05 ± 4·30 | 0·11 |
TCRγδ+ CD8α+ CD8β− | 0·89 ± 0·30 | 0·33 ± 0·42 | < 0·01 |
All data given as mean ± s.d.